Home - (not)DumbMoney

Silexion Therapeutics Selects Contract Research Organization for Phase 2/3 Trials

Silexion Therapeutics announces the selection of AMS Advanced Medical Services GmbH as the CRO to support upcoming Phase 2/3 clinical trials for SIL204, targeting KRAS-driven solid tumor cancers.

Brookfield Asset Management Announces Pricing of $750 Million Notes Due 2055

Brookfield Asset Management Ltd. announced the pricing of $750 million senior notes due in 2055.

Thumzup Media Corporation's Strategic Transformation into a Cryptocurrency Mining Leader

Thumzup Media Corporation highlighted its strategic transformation into a leader in cryptocurrency mining.

Huntsman Announces Retirement of David Stryker and Appointment of New Executive Vice President

Huntsman Corporation announced the retirement of David Stryker, the current General Counsel, and the appointment of Julia Wright as the new Executive Vice President, General Counsel, and Secretary.

Century Communities Announces Pricing of Private Offering of $500 Million of Senior Notes due 2033

Century Communities, Inc. announced the pricing of its private offering of $500 million aggregate principal amount of 6.625% Senior Notes due 2033.

Star Equity Holdings, Inc. Announces Name Change and Ticker Symbol Transition

Hudson Global, Inc. changed its name to Star Equity Holdings, Inc. and its ticker symbols to STRR and STRRP on NASDAQ.

Silgan Announces Pricing of New Senior Notes Offering

Silgan Holdings Inc. announced the pricing of its new senior unsecured notes offering.

Convertible Promissory Note Agreement between Sky Quarry Inc. and Varie Asset Management LLC

Sky Quarry Inc. issued a Convertible Promissory Note of $175,000 to Varie Asset Management LLC on August 29, 2025.

ALT5 Sigma Corporation Announces $WLFI Holdings Rise to Approximately 7.28 Billion Tokens

ALT5 Sigma Corporation announces the increase in its $WLFI holdings to approximately 7.28 billion tokens.

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Vivani Medical, Inc. plans to initiate a Phase 1 clinical study for the NPM-139 semaglutide implant in the first half of 2026.

Sweetgreen Announces Retirement of CFO and Appointment of New CFO

Sweetgreen, Inc. announced the retirement of Mitch Reback, the current Chief Financial Officer, and the appointment of Jamie McConnell as the new CFO.

TPG RE Finance Trust, Inc. Announces Share Repurchase Program

TPG RE Finance Trust, Inc. announced a new share repurchase program totaling $25.0 million for its common stock.

Syntec Optics Holdings, Inc. Receives Nasdaq Delinquency Notice

Syntec Optics Holdings, Inc. received an additional delinquency notification letter from the Nasdaq Listing Qualifications.

STRATA Skin Sciences Closes $2.42 Million Registered Direct Offering

STRATA Skin Sciences, a medical technology company, concluded a registered direct offering issuing 1,097,547 shares at $2.204 per share.

American Outdoor Brands, Inc. Reports First Quarter Fiscal 2026 Financial Results

American Outdoor Brands, Inc. announced financial results for the first quarter fiscal 2026 ended July 31, 2025.

Marriott Vacations Worldwide Announces Pricing of $575 Million of 6.500% Senior Notes

Marriott Vacations Worldwide Corporation announced the pricing of $575 million aggregate principal amount of 6.500% senior notes due 2033.

Wynn Macau, Limited 2025 Interim Report Highlights

Wynn Macau, Limited is a developer, owner, and operator of two integrated destination casino resorts, Wynn Palace and Wynn Macau, located in the Greater Bay Area region of the People's Republic of China.

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline

Aptevo Therapeutics Inc. announces the expansion of its anti-cancer pipeline with the introduction of two new trispecific candidates, APVO452 and APVO451, targeting prostate cancer and multiple solid tumor types.

Broadcom Inc. Announces Record Third Quarter Fiscal Year 2025 Results and Dividend

Broadcom Inc. reported revenue of $15,952 million for the third quarter, marking a 22% increase from the previous year period.

Guidewire Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Guidewire announced its financial results for the fiscal quarter and year ended July 31, 2025.

Copart Reports Fourth Quarter Fiscal 2025 Financial Results

Copart, Inc. reported $1.1 billion in revenue for the quarter ending July 31, 2025, with a 5.2% increase from the same period last year.

Quanex Building Products Announces Third Quarter 2025 Results

Quanex Building Products announced its financial results for the third quarter of 2025, showing significant growth in net sales compared to the previous year.

eGain Announces Increase to Stock Repurchase Program of $20 Million

The AI knowledge platform eGain (Nasdaq: EGAN) announced a $20 million increase in its stock repurchase program.

UiPath Reports Strong Second Quarter Fiscal 2026 Financial Results

UiPath, Inc. announced financial results for its second quarter fiscal 2026, with revenue reaching $362 million and an 11% year-over-year increase in ARR to $1.723 billion.

Weyerhaeuser Investor Presentation - September 2025 Highlights

Weyerhaeuser presented their investor overview for 2025 showcasing their unmatched portfolio and industry-leading performance.

Zumiez Inc. Announces Fiscal 2025 Second Quarter Results

Zumiez Inc. reported positive results for the second quarter of fiscal 2025, with net sales increasing to $214.3 million.

Lumen Technologies, Inc. Announces Offering of Additional First Lien Notes Due 2034

Lumen Technologies, Inc. announced the offering of $425 million aggregate principal amount of its 7.000% First Lien Notes due 2034 through its subsidiary, Level 3 Financing, Inc.

Lumen Announces Offering of Additional First Lien Notes Due 2034

Lumen Technologies, Inc. (NYSE: LUMN) plans to offer $425 million aggregate principal amount of its 7.000% First Lien Notes due 2034.

Braze Reports Fiscal Second Quarter 2026 Results

Braze, the leading customer engagement platform, announced strong results for the second quarter of 2026.

Lululemon Athletica Inc. Announces Second Quarter Fiscal 2025 Results

Lululemon Athletica Inc. reported a 7% increase in revenue to $2.5 billion for the second quarter of fiscal 2025.

Samsara Reports Second Quarter Fiscal Year 2026 Financial Results

Samsara reported strong second-quarter fiscal year 2026 financial results with significant year-over-year growth in revenue and ARR.

Ramaco Retains Hatch to Lead Pre-Feasibility Study for Brook Mine REE/CM Project

Ramaco Resources, Inc. announces the retention of Hatch Ltd. to lead the Pre-Feasibility Study for the Brook Mine project.

Docusign Announces Second Quarter Fiscal 2026 Financial Results

Docusign, Inc. (NASDAQ: DOCU) announced its financial results for the fiscal quarter ended July 31, 2025.

CSG Announces Contract Extension with Charter Communications

CSG and Charter Communications signed a multi-year contract extension and expansion of their decades-long relationship.

PRO-DEX, INC. Fiscal 2025 Results: Growth in Sales and Income

PRO-DEX, INC. announced its financial results for the fiscal 2025 fourth quarter and full-year ended June 30, 2025.

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

iSpecimen Inc. is pursuing a strategic initiative to integrate digital assets into its business model by building a $200 million corporate treasury reserve based on the Solana blockchain ecosystem.

Concrete Pumping Holdings Reports Third Quarter Fiscal Year 2025 Results

Concrete Pumping Holdings reported financial results for the third quarter ended July 31, 2025.

CB Financial Services, Inc. Authorizes New Stock Repurchase Program

CB Financial Services, Inc. announced a program to repurchase up to $5 million of the Company's outstanding shares of common stock.

Replimune Announces Type A Meeting Scheduled with FDA

Replimune Group, Inc., a clinical stage biotechnology company, has scheduled a Type A meeting with the FDA to discuss the complete response letter for RP1 in combination with nivolumab for the treatment of advanced melanoma.

ServiceTitan Announces Fiscal Second Quarter Financial Results

ServiceTitan announced financial results for the fiscal second quarter ended July 31, 2025.

Torrid Reports Second Quarter 2025 Results

Torrid Holdings Inc. announced its financial results for the quarter ended August 2, 2025.

Argan, Inc. Reports Record Backlog of $2.0 Billion in Second Quarter Fiscal 2026

Argan, Inc. reported its financial results for the second quarter of fiscal year 2026, showing growth in revenues and profits.

Smith & Wesson Brands, Inc. Reports First Quarter Fiscal 2026 Financial Results

Smith & Wesson Brands, Inc. reported Q1 net sales of $85.1 million with a gross margin of 25.9%.

Phreesia Announces Second Quarter Fiscal 2026 Results and AccessOne Acquisition

Phreesia announced their financial results for the fiscal second quarter ended July 31, 2025, showcasing significant growth in revenue and net income.

Ambiq Reports Strong Second Quarter 2025 Financial Results with 13.6% Revenue Increase

Ambiq Micro, Inc. reported its financial results for the second quarter of 2025, showing a 13.6% sequential increase in net sales to $17.9 million.

LifeVantage Reports Strong Financial Results for Q4 and Fiscal Year 2025

LifeVantage Corporation announced its financial results for the fourth quarter and full fiscal year 2025, showcasing significant revenue growth and earnings improvement.

Indaptus Therapeutics Provides Clinical Update for INDP-D101 Trial

Indaptus Therapeutics provides a clinical update on the ongoing INDP-D101 trial, highlighting positive outcomes and progress in their Decoy platform.

McEwen Reports Attractive Gold Intercepts at Grey Fox Project

McEwen Inc. reports attractive gold grades and widths at the Gibson Expansion Zone and Grey Fox South (GFS) within the Grey Fox Project.

eGain Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Stock Repurchase Program Expansion

eGain announced financial results for its fiscal 2025 fourth quarter and full fiscal year ended June 30, 2025.

DarkPulse Signs Consultancy Agreement with BX3 for Global Expansion

DarkPulse, Inc. announces a consultancy agreement with BX3 International FZ-LLC to drive sales in the Middle East, Africa, and Asia.

Nova LifeStyle, Inc. Announces Pricing of $8.71 Million Best-Efforts Public Offering

Nova LifeStyle, Inc. announced the pricing of its best-efforts public offering of up to 9,522,393 shares of common stock and up to 19,044,786 warrants.

JAMA Publishes Results of MM120 Clinical Trial in Generalized Anxiety Disorder

The Journal of the American Medical Association (JAMA) recently published the results of a groundbreaking clinical trial on MM120 for treating Generalized Anxiety Disorder (GAD).

Wiley's First Quarter 2026 Results Showcase Demand for AI

Wiley reports results for Q1 ending July 31, 2025

Options Analysis of Canadian Derivatives Clearing Corporation

The options analysis for Canadian Derivatives Clearing Corporation provides insights into various equity options and underlying instruments.

Limitless X Holdings Issues Shareholder Letter Detailing Strategic Transformation, Reg A+ Qualification, Capital Markets Milestones, and Near-Term Growth Outlook

Limitless X Holdings has undergone a strategic transformation, shifting to a fully integrated platform in the health and wellness industry.